$300M Series D funding secured & Dr. Omar Ishrak appointed Biofourmis Chairman Learn More
Biofourmis’ AI-driven predictive analytics and end-to-end solutions provide care to patients from nearly any location. By harnessing the power of hospital-grade wearables and patient-centric tools, clinicians are able to predict clinical events and stay one step ahead of patient deterioration, driving improved clinical and economic outcomes.
Would you like to schedule a demo? Click here.
BIOFOURMIS AG
Kreuzstrasse 2
8008 Zurich
Switzerland